Literature DB >> 8694640

Revascularization using angioplasty and minimally invasive techniques documented by thermal imaging.

R W Emery1, A M Emery, T F Flavin, M D Nissen, M R Mooney, K V Arom.   

Abstract

Minimally invasive direct coronary artery bypass grafting offers mortality and morbidity advantages to selected patients. To broaden indications for such, an appropriate and combined disciplinary approach using angioplasty and minimally invasive direct coronary artery bypass grafting is described in a patient requiring reoperative grafting. Documentation of patency of new left internal mammary artery-to-left anterior descending artery anastomoses performed without the use of cardiopulmonary bypass was obtained intraoperatively using a Thermal Imaging Camera.

Entities:  

Mesh:

Year:  1996        PMID: 8694640

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Hybrid revascularization feasibility in minimally invasive direct coronary artery bypass grafting combined with percutaneous transluminal coronary angioplasty in patients with acute coronary syndrome and multivessel disease.

Authors:  Y Matsumoto; M Endo; F Kasashima; Y Abe; I Kosugi; Y Hirano; H Sasaki; T Ueyama
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-12

2.  Myocardial "hybrid" revascularisation with minimally invasive direct coronary artery bypass grafting combined with coronary angioplasty: preliminary results of a multicentre study.

Authors:  T Wittwer; J Cremer; P Boonstra; J Grandjean; M Mariani; A Mügge; H Drexler; P den Heijer; E R Leitner; A Hepp; M Wehr; A Haverich
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

3.  Interventionist videothermometry: a new model of cardiac ischemia evaluation.

Authors:  Tomas Ottoni Barroso da Silva; Leonardo Waldstein de Moura Vidal; Paula Gebe Abreu Cabral; Matheus Roberto da Mota Costa; Silvia Marcela Ruiz Cadena; Marcelo Borges Dos Santos Junior; Fernanda Antunes; André Lacerda de Abreu Oliveira
Journal:  BMC Vet Res       Date:  2020-05-19       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.